French food maker Danone confirmed on Wednesday that it has halted distribution of a specifically manufactured batch of infant formula destined for Singapore after receiving a formal request from the Singapore Food Agency (SFA). The affected batch, produced at Danone’s Wexford, Ireland, facility in early December, comprised approximately 150 metric tons and was formulated to meet local nutrient specifications, including elevated levels of iron and DHA. Danone has initiated an internal quality review and is collaborating closely with SFA inspectors, who reported no immediate health incidents linked to the products. The company has also offered to conduct additional laboratory testing, including microbiological assays and nutrient profiling, to address regulator concerns. While Danone expects the hold to be lifted within two weeks, management noted the action underscores the importance of stringent compliance in its infant nutrition segment, which represents roughly 12% of the company’s €25 billion annual revenue and is a strategic growth area in the Asia-Pacific region.